Jeffrey Norton
Academic Appointments
- Professor - Med Center Line, Surgery - General Surgery
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Surgical Oncology 875 Blake Wilbur Drive, Clinic F MC 5826 Stanford, CA 94305-5820 Tel Work (650) 498-6000 Fax (650) 736-4167
- Academic Offices
Personal Information Email Tel (650) 498-6606 Tel (650) 498-6000Alternate Contact JoAnn Smithson Administrative Assistant Email Tel Work (650) 498-6606Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> GI Oncology
- Adrenal Cancer
- Carcinoid Tumors
- Carcinoid Tumors - Endocrinology
- Carcinoid Tumors - Surgery
Professional Education
| Board Certification: | General Surgery, American Board of Surgery (1983) |
| Residency: | Duke University Medical Center NC (1982) |
| Fellowship: | National Cancer Institute MD (1979) |
| Internship: | Duke University Medical Center NC (1974) |
| Medical Education: | SUNY Upstate Medical University NY (1973) |
Scientific Focus
Current Research Interests
Interleukin-12 is a Th1 cytokine. It is important in the cell mediated immune response. We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer. We are planning a human trial.
Clinical Trials
- Identification of Key Blood Molecular Markers for Immunotherapy Recruiting
- Pancreatic Cancer and the Pre-Metastatic Liver Niche Recruiting
- Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma Recruiting
- Prognostic Value of Baseline CT Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection Recruiting
- Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample Completed
Publications
- Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis. Ann Surg Oncol. 2012
- Recurrent Duodenal Stricture Secondary to Untreated Crohn''s Disease. Dig Dis Sci. 2012
- A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol. 2011; (9): 2594-8
- Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma. Int J Radiat Oncol Biol Phys. 2011
- Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection. Arch Surg. 2011; (6): 724-32
